100% Quality Guarantee
PhD-Level Technical Support
Biotinylated Anti-BTN3A1 antibody (HDLA054)
Key Features

Anti-BTN3A1 Biotinylated Recombinant Rabbit Monoclonal Antibody (HDLA054)

SKU HDLA054
Product Type Rabbit Monoclonal Antibody
Antibody Type Monoclonal Antibody
Size 100 μg
Reactivity Human
Host Species Rabbit
Antibody Isotype Rabbit Igg
Clone DM92
Synonyms BTN3A1, BTF5, CD277, BTN3.1, BT3.1
€1,173

Request a formal quotation

A PDF quote with its own quote number, ready for your purchasing office to raise a PO against. Back within 4 working hours, from a PhD scientist — not an autoresponder.

  • PO-ready PDFQuote number, VAT, Incoterms
  • Volume pricing appliedDiscounts from 2 kits up
  • Valid 30 daysPrices held while you get sign-off
Anything we should know? optional

No account needed. We use your details only to prepare and send this quote. If it's urgent, say so in the box and we'll come back the same working day.

Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheetsystem_update_altMSDS

Anti-BTN3A1 Biotinylated Recombinant Rabbit Monoclonal Antibody (HDLA054)

The Biotinylated Anti-BTN3A1 Antibody (HDLA054) is a valuable tool for research involving BTN3A1, a cell surface protein involved in immune regulation and activation. This antibody, produced in-house and rigorously validated, is highly specific for BTN3A1 and is ideal for use in various applications such as immunofluorescence, flow cytometry, and immunoprecipitation.BTN3A1, also known as CD277, is a member of the B7 family of immune checkpoint molecules and plays a crucial role in modulating immune responses. It has been implicated in the regulation of T cell activation and proliferation, making it a promising target for immunotherapy and cancer research.

By targeting BTN3A1, researchers can gain insights into the mechanisms of immune regulation and potentially develop novel therapies for cancer and other immune-related disorders.Overall, the Biotinylated Anti-BTN3A1 Antibody (HDLA054) offers researchers a reliable and specific tool for studying BTN3A1 and its role in immune modulation, making it a valuable asset for studies in immunology, oncology, and related fields.

View AllClose

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose